Navigation Links
CMC Biologics und RuiYi Enter treffen Vereinbarung zur Entwicklung eines neuartigen monoklonalen Anti-IL-6-Antikörpers
Date:5/14/2013

SEATTLE, KOPENHAGEN, Dänemark und SHANGHAI, 14. Mai 2013 /PRNewswire/ -- CMC Biologics gab heute die Unterzeichnung einer Vereinbarung mit RuiYi Inc. zur Entwicklung einer Zelllinie für RYI-008, einen neuartigen monoklonalen Anti-IL-6-Antikörper, bekannt. Das proprietäre hochproduktive CHEF1®-Exprimierungsplasmid von CMC Biologics soll zur Zelllinienentwicklung genutzt werden, um das Zellwachstum und eine gleichmäßig hohe Proteinexprimierung innerhalb eines engen Zeitrahmens zu optimieren. Die genauen Vertragsbedingungen wurden nicht genannt.

„Wir freuen uns auf die Zusammenarbeit mit CMC Biologics, einem weltweit tätigen Auftragshersteller, der für seine herausragenden technischen Leistungen in der biopharmazeutischen Entwicklung und der cGMP-Herstellung bekannt ist", sagte Paul Grayson , Geschäftsführer und CEO von RuiYi. „Durch seine integrierten Dienstleistungen, darunter die Zelllinienentwicklung mit dem proprietären CHEF1-System, zusammen mit seiner guten Ansprechbarkeit und Kooperationsbereitschaft ist CMC Biologics unser Partner der Wahl für dieses wichtige globale Unterfangen."

„Wir freuen uns über die Gelegenheit, durch die Entwicklung von RYI-008 eine langfristige Beziehung zu RuiYi aufzubauen. RYI-008 ist ein erstaunlich kraftvoller Antikörper mit einer bemerkenswerten Halbwertzeit, der große Chancen bietet, auf dem sich rasch entwickelnden Gebiet der IL-6-Biologie ein herausragendes Produkt zu erschaffen", so Mark Sawicki , PhD, Global Vice President Business Development von CMC Biologics. „Diese Vereinbarung unterstreicht unseren strategischen Fokus auf der Entwicklung von Biopharmaka in aufstrebenden Märkten."

Informationen zu CMC Biologics
CMC Biologics ist ein Hersteller und Entwickler, der sich spez
'/>"/>

SOURCE RuiYi Inc.; CMC Biologics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CMC Biologics et RuiYi passent un accord pour le développement dun nouvel anticorps monoclonal Anti-IL-6
2. CMC Biologics and RuiYi Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody
3. Huahai and Oncobiologics Create Broad Biosimilars Partnership
4. Positron And Biologics Modular Enter Into Co-Marketing Agreement
5. Panelists Announced for Decision Resources Group One-day Biologics and Biosimilars Seminar in San Diego
6. Synthetic Biologics Reports Year End 2012 Financial Results
7. Both Biosimilar and Reference Biologics Companies Must consider Various Product-Specific and Regional Strategies to Navigate a Dynamic and Uncertain Global Market
8. CMC Biologics remporte le CMO Leadership Award 2013 pour linnovation, la qualité et la fiabilité
9. CMC Biologics gewinnt 2013 CMO Leadership Award für Innovation, Qualität und Zuverlässigkeit
10. CMC Biologics Wins 2013 CMO Leadership Award for Innovation, Quality and Reliability
11. Synthetic Biologics to Present at the 25th Annual ROTH Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  UBM Medica US ... leading online community for medical imaging professionals, presents special ... for Medical Imaging Management,s 2014 Annual Meeting . ... coverage: , 11 Principles of Successful ... lead to greater profitability. , Why Don,t ...
(Date:8/27/2014)... 2014 /PRNewswire-iReach/ -- "Fatty Liver Disease Global Clinical Trials ... Disease clinical trial scenario. This report provides elemental information ... Fatty Liver Disease . It includes an overview of ... the site of trial conduction across the globe. The ... by their phase, trial status, prominence of the sponsors ...
(Date:8/27/2014)... CITY, Calif. , Aug. 27, 2014 /PRNewswire-iReach/ ... emergency response system design, blended emergency medical training ... CPR/AED (automated external defibrillator) training from the ... the Army Reserve 81 st Regional ... Security and Investigations contract includes nationwide CPR/AED/First Aid ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 2Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 3Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 4Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 5Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 3
... ... ... - SORT OUT III Data Presented at American College of Cardiology Meeting,in Atlanta and Published in the Lancet , ... , , ...
... Md. , March 17 Micromet, Inc. (Nasdaq: MITI ) announced today the closing of its previously ... shares of common stock. As a result, Micromet sold a total of 11.5 million shares of its common stock at ... ... , , ...
Cached Medicine Technology:Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 2Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 3Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 4Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 5Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 6Micromet Closes $80.5 Million Public Offering of Common Stock 2Micromet Closes $80.5 Million Public Offering of Common Stock 3Micromet Closes $80.5 Million Public Offering of Common Stock 4
(Date:8/27/2014)... 27, 2014 With most forms ... sense to use hearing protection when exposed to ... are many different forms of hearing protection ... provide hearing protection training and devices for workers ... industries. The National Institute of Occupational Safety and ...
(Date:8/27/2014)... time you experienced worrisome medical symptoms, did you ... professional? If so, you,re not alone. Consumers are ... support groups to gather anecdotal information and advice, ... trustworthy sources. New research to be presented at ... the characteristics of consumers who use the Internet ...
(Date:8/27/2014)... 27, 2014 (HealthDay News) -- A new genetic discovery ... fight the bowel disorder, researchers report. The ... affect how their genes work, and said these changes ... raising the possibility of a simple diagnostic test for ... disease develops and suggest possible gene targets for new ...
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... occurs when red blood cells are in short supply or ... body does not get enough oxygen, since there are fewer ...
(Date:8/27/2014)... 8/27/14)Dartmouth cancer researchers developed and tested an advanced ... interactions that contribute to disease as published yesterday ... The approach fills a gap in current analyses. ... interactions among genetic and environmental factors. When many ... versus those that reflect chance combinations among affected ...
Breaking Medicine News(10 mins):Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 2Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 3Health News:Educated consumers more likely to use potentially unreliable online healthcare information 2Health News:Scientists Spot Genetic Clues to Crohn's Disease 2Health News:Drug represents first potential treatment for common anemia 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2
... 7-day old baby was charred to death due to a short ... their joy and hopes. The incubator in which the baby was ... incident had happened due to negligence of the hospital staff while ... were saved due to prompt action of the medical staff who ...
... The doctor, who had dismissed increased risk of heart attack ... that his views are 'out of the mainstream' as it ... company, Merck and Co. ,Thomas Cona and John ... the drug had resulted in heart attacks. More than 10, ...
... of the biggest problems worldwide. There is an urgent ... these new antibiotic resistant infections. // Researchers at ... say they have used natural bacteria living in soil ... discovery would allow scientists race ahead in developing antibiotics ...
... behind the alleged leak of question papers of the MD/MS ... India Institute of Medical Sciences (AIIMS), // has been ... Madurai Medical College. ,Satish Kumar (26),an MD (Paediatric) ... and two other doctors have been taken into custody ...
... (PTSD) is a disabiling anxiety disorder, which was first ... War I, as soldier's heart and shell shock respectively. ... are affected by cancer and their families as well ... affects about 10 percent of those exposed to extreme ...
... shared between India and China. The world's fastest growing ... to tackle the // problem of this latest threat. , ... Du Qinglin met and discussed management of avian influenza ... was agreed that exchange of information and technical cooperation between ...
Cached Medicine News:Health News:The Face Of Indian Health Care: A World Health Day Evaluation 2Health News:The Face Of Indian Health Care: A World Health Day Evaluation 3Health News:The Face Of Indian Health Care: A World Health Day Evaluation 4Health News:Doctor Grilled In Court For False Report About Vioxx Health Risk 2Health News:New Therapy For Treating Post-Traumatic Stress Syndrome 2
... CVA for CELL-DYN are assayed linearity control ... and to verify patient reportable range of ... also measure the linear performance of the ... have customized ranges appropriate for each instrument ...
The technology in the LATITUDE system allows your doctor to get the same data from your device whether you are at home or in your doctor's office. This information transfer happens automatically....
... Proprietary EX.P.R.T. Release ... jumping,, No stent shortening,, Unique anatomically ... in the carotid bifurcation,, 0.014 Rapid ... crossing profile and flexible atraumatic tip,, ...
... Para 5X is a whole blood ... Pentra 60C+, 80 and 120, and the ... product offers a unique white cell differential, ... the algorithms on the systems. The product ...
Medicine Products: